News

Avenda Health’s Unfold AI™ Shown to More Precisely Predict Extraprostatic Extension Risk in Prostate Cancer Patients, Surpassing Conventional Methodology

Avenda Health Announces First Commercial Use of Unfold AI on Prostate Cancer Patients in the U.S.

Prostate Cancer Technology Startup, Avenda Health, Partnering with BioscienceLA to Establish New Life Sciences Innovation Hub in U.S.

First AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuest Receives FDA Clearance

December 13, 2022

Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance

December 11, 2022

Could an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?

December 7, 2022

News, Recognition

Avenda Health Adds Tech Luminary to Board of Directors and Expands Leadership Team

August 26, 2022

News, Recognition

Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy

August 10, 2022